Here are the most promising coronavirus vaccine candidates out there By Yasemin Saplakoglu Scientists around the world are creating dozens of unique vaccine candidates to fight the novel coronavirus — and they're doing it at unprecedented speeds.
SARS-CoV-2 relative found lurking in frozen bats from Cambodia By Nicoletta Lanese For the first time, close relatives of the novel coronavirus have been found outside China.
Americans celebrated Thanksgiving during a pandemic before. Here's what happened. By Brandon Specktor How did Americans celebrate the holidays during the influenza pandemic of 1918? With a lot of partying, turns out.
Oxford COVID-19 vaccine up to 90% effective (with the right dose) By Yasemin Saplakoglu A third major coronavirus vaccine candidate has revealed promising results in late-stage trials.
Rural hospitals are under siege from COVID-19. Here's what doctors are facing, in their own words. By Lauren Hughes, Jennifer Bacani McKenney It’s difficult to put into words how hard COVID-19 is hitting rural America’s hospitals.
Could COVID-19 immunity last decades? Here’s the science. By Nicoletta Lanese Of course, rare cases of reinfection show that immunity is not long-lasting for everyone.
Speed of COVID vaccine testing did not compromise safety, Fauci says By Yasemin Saplakoglu This incredible speed in vaccine development is unprecedented, but the process is solid.
CDC urges Americans not to travel for Thanksgiving By Rachael Rettner The safest way to celebrate Thanksgiving is at home with people in your household, the agency said.
Mysteries of COVID smell loss finally yield some answers By Stephani Sutherland Explanations begin to arise at the molecular level for this vexing but commonplace symptom
Woman's stomach pain turns out to be rare case of 'wandering spleen' By Nicoletta Lanese The organ shifted when ligaments around it became loose.
FDA authorizes 1st fully at-home COVID-19 test By Rachael Rettner The test, made by Lucira Health in California, requires a prescription.
Pfizer vaccine is 95% effective, company to seek FDA approval within days By Yasemin Saplakoglu The final efficacy analysis of its late-stage trial suggest Pfizer and BioNtech's vaccine is safe and effective at preventing COVID-19.
What are monoclonal antibodies? (And why do we need them?) By Rodney E. Rohde Here's why we need monoclonal antibodies to the coronavirus as well as a vaccine.
How early was the coronavirus really circulating in Italy? By Yasemin Saplakoglu A new study suggests as early as September of last year, but some experts are skeptical.
Olympic officials 'very confident' that next year's games in Tokyo will have spectators By Rachael Rettner Japan was scheduled to host the Olympic Games in the summer of 2020, but the coronavirus pandemic forced officials to postpone the competition until 2021.
Moderna coronavirus vaccine is 94.5% effective, early results suggest By Yasemin Saplakoglu This comes a week after Pfizer announced similar results, providing hope that the world may soon have multiple vaccines that work effectively.
This interactive tool figures out your COVID-19 risk of attending an event By Clare Watson Planning to attend an event but unsure of the COVID-19 risk, and if you should go at all? There's an evidence-based interactive webtool that can help.
SpaceX's Elon Musk says he's tested positive for COVID-19 on eve of NASA astronaut launch By Meghan Bartels SpaceX CEO Elon Musk has announced that he has received mixed results from tests meant to diagnose infections of the novel coronavirus.
